US 5,534,615 A · Cardiac hypertrophy factor and uses therefor

Abstract

Isolated CHF, isolated DNA encoding CHF, and recombinant or synthetic methods of preparing CHF are disclosed. These CHF molecules are shown to influence hypertrophic activity and neurological activity. Accordingly, these compounds or their antagonists may be used for treatment of heart failure, arrhythmic disorders, inotropic disorders, and neurological disorders.

Claims1

Dependent claims

Isolated CHF having the translated CHF amino acid sequence (SEQ ID NO:

3) shown in FIG. 1.

Dependencies are inferred from the claim text.

Facts

Application

08/233,609Filed 25 Apr 1994

Granted

9 Jul 1996

Term ends

Not estimatedThe source records don’t support an estimate.

Classification19 codes

G01N 33/5008
Involving human or animal cells: for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
C07K 14/52
From animals; from humans: cytokines; Lymphokines; Interferons
C12Q 1/025
Involving viable microorganisms: for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
G01N 33/502
For testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics: for testing non-proliferative effects

Cardiac hypertrophy factor and uses therefor

Life of this patent

Abstract

Claims1

Cardiac hypertrophy factor and uses therefor

Life of this patent

Abstract

Claims1